A phase 3 trial of the effectiveness of Gilenya (fingolimod) on primary progressive MS ended in September. Has anyone heard any results ?
john h
Nothing posted yet on this site.
I was at a newly diagnosed course last week, with seminars from ms specialists. They were talking about this trial and were expecting a result before Christmas or January at the latest. I hope it’s a positive result!
Hth
Oh, that’s a shame. There is much more research going on for the progressive forms now, hopefully there will be a breakthrough soon.